Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Qualitative Assessment of Implementing Routine Rapid HIV Testing

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT00680862
First received: May 15, 2008
Last updated: September 26, 2014
Last verified: September 2014
Results First Received: August 27, 2014  
Study Type: Observational
Study Design: Observational Model: Cohort;   Time Perspective: Cross-Sectional
Condition: HIV Infections

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Group 1 VA employees

Participant Flow:   Overall Study
    Group 1
STARTED   25 
COMPLETED   25 
NOT COMPLETED   0 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
VA employees

Reporting Groups
  Description
Group 1 VA employees

Baseline Measures
   Group 1 
Overall Participants Analyzed 
[Units: Participants]
 25 
Age 
[Units: Years]
Mean (Standard Deviation)
 36  (2) 
Age 
[Units: Participants]
 
<=18 years   0 
Between 18 and 65 years   25 
>=65 years   0 
Gender 
[Units: Participants]
 
Female   0 
Male   25 
Region of Enrollment 
[Units: Participants]
 
United States   25 


  Outcome Measures

1.  Primary:   Number of Participants Who Completed the Survey   [ Time Frame: 6 months ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Henry Anaya
Organization: VHA
phone: 310-478-3711 ext 48488
e-mail: henry.anaya@va.gov


Publications of Results:

Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT00680862     History of Changes
Other Study ID Numbers: SHP 08-158
Study First Received: May 15, 2008
Results First Received: August 27, 2014
Last Updated: September 26, 2014
Health Authority: United States: Federal Government